Companies: 10,795·Total market cap: $144.5T
GlobeImmune, Inc.

GlobeImmune, Inc.

GBIMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$575
P/E Ratio—
52W High$0.0005
52W Low$0.000001
Overview

GlobeImmune, Inc. (GBIM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001245104 · GBIM · OTC · as of Jun 9, 2026

Filing snapshot

153
Total Filings
D
Latest Form
2017-03-23
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001245104 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2016-04-28
Fiscal Year End
Apr 28, 2016
Accession No.
0001564590-16-016966
Primary Document
gbim-10ka_20151231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001245104 · Accession 0001564590-16-016966

Latest Key Filings

10-QQuarterly Report
10-Q
2016-05-12
View 10-Q on SEC
8-KCurrent Report
8-K
2016-07-05Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
DD
D
2017-03-23
View
15-12B15-12B
15-12B
2016-07-25
View
S-8 POSS-8 POS
S-8 POS
2016-07-15
View
S-8 POSS-8 POS
S-8 POS
2016-07-15
View
2525
25
2016-07-15
View
8-KCurrent Report
8-K
2016-07-05
View
CT ORDERCT ORDER
CT ORDER
2016-06-20
View
8-KCurrent Report
8-K
2016-05-19
View
8-KCurrent Report
8-K
2016-05-12
View
10-QQuarterly Report
10-Q
2016-05-12
View
10-K/AAnnual Report (Amended)
10-K/A
2016-04-28
View
8-KCurrent Report
8-K
2016-03-16
View
10-KAnnual Report
10-K
2016-03-16
View
SC 13GBeneficial Ownership Report
SC 13G
2016-02-24
View
8-KCurrent Report
FORM 8-K
2016-02-23
View
Showing 1–15 of 115 filingsForm 4 / 144 hidden· 153 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001245104  |  Exchange: OTC · Healthcare

GlobeImmune, Inc. (OTC: GBIM) has submitted 153 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001245104, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is GlobeImmune, Inc.'s most comprehensive regulatory disclosure. The most recent GlobeImmune, Inc. 10-K was filed on 2016-04-28 for fiscal year ending 2016. Historical GBIM 10-K annual reports are available from 2003 through 2016.

Investors researching GlobeImmune, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ANTH SEC Filings →FPMI SEC Filings →RBSH SEC Filings →SNNAQ SEC Filings →CMRA SEC Filings →SYVC SEC Filings →IAGX SEC Filings →NTII SEC Filings →
→ GBIM Financials→ GBIM Earnings→ GBIM Insider Trades

Frequently Asked Questions

GBIM SEC Filings · 8 questions

GlobeImmune, Inc. (GBIM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 153 filings and access original documents at no cost. GlobeImmune, Inc.'s CIK is 0001245104.

GBIM SEC filingsGlobeImmune, Inc. SEC documentsfind GBIM 10-K